Posts in tag

SSSI


Novo Nordisk to discontinue the Protaphane InnoLet human insulin (rys) 100 IU/mL injection multidose cartridge on 1 February 2025  Pharmacists can now use a Serious Scarcity Substitution Instrument (SSSI) to …

New SSSI allows pharmacists to substitute different brands and strengths of estradiol patches due to scarcity With serious shortages of estradiol transdermal patches, new legislation allows pharmacists to supply patches …

Pharmacists say SSSIs should not be required for substitutions which amount to “doing primary school maths sums” In their submissions to the Therapeutic Goods Administration’s Medicines Shortages in Australia – …

TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues  Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s …

Pharmacists authorised to substitute Orencia 125mg/mL products to deal with shortages  The Therapeutic Goods Administration (TGA) has issued a Serious Scarcity Substitution Instrument (SSSI) in response to shortages of both …

Temporary approval granted for replacement oral fluoxetine product as shortage continues Due to the shortage of fluoxetine (brand name: Zactin Tablet), the Federal Department of Health has announced it has …

The TGA has made a Serious Scarcity Substitution Instrument regarding fluoxetine 20mg dispersible tablets To help manage the shortage of the dispersible tablet form of this dose, the Therapeutic Goods …

PBS confirms subsidy arrangements for vigabatrin under a serious scarcity substitution instrument (SSSI)  An amendment to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination …

A Serious Scarcity Substitution Instrument has been made for Ryzodeg 70/30 FlexTouch Pharmacists can now substitute Ryzodeg 70/30 Penfill cartridges instead of Ryzodeg 70/30 FlexTouch prefilled pen under certain conditions, …

An unexpected increase in demand for oral liquid preparations of cefaclor have prompted the Therapeutic Goods Administration (TGA) to issue a Serious Scarcity Substitution Instrument (SSSI) for the medication  Pharmacists …

Manufacturing issues responsible for Phenoxymethylpenicillin drought, says regulator A Serious Scarcity Substitution Instrument (SSSI) has been made by the Therapeutic Goods Administration (TGA) to help manage the shortage of the …